HopeStage
Back to all studies
TerminatedNCT02813447

Safety of Anti-Depressant for Chronic Obstructive Pulmonary Disease (SAD-COPD)

Medication studyAges 40+United StatesAnxiety
The study in practice

Understand this study

Who could participate?

Listed age limits: from 40 years.

Listed locations
DurhamSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: August 2016
Recruitment status
Terminated
Enrollment listed in the registry
13
Sponsor
Duke University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
Over 40 Years
Official registry ID
NCT02813447
Official title
Show the full official title

Safety of Anti-Depressant for Chronic Obstructive Pulmonary Disease

Recruitment & locations

Terminated

Durham

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Duke University, a university.

Does this study involve medication?

Yes. The study involves medication, including Sertraline and Placebo.

Who can participate?

Listed age limits: from 40 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies